-
Daily Use of a Muscle Pump Activator Device Reduces Hospitalization and Improves Graft Function Post Transplantation: A Randomized Controlled Trial
-
Damage-Associated Molecular Pattern Release and Toll-Like Receptor Activation during Cold Storage and Ex Vivo Reperfusion of Old Rat Livers
-
Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period
-
Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient
-
De Novo Belatacept to Delay Tacrolimus Initiation in Renal Transplants with Delayed Graft Function
-
De Novo Complement-Activating Donor Specific Antibodies in Pediatric Renal Transplant Recipients Are Highly Responsive to Therapy
-
De Novo Donor Specific Antibody and Panel Reactivity Antibody Are Critical Risk Factors for Antibody Mediated Rejection of Kidney Allograft after Simultaneous Liver-Kidney Transplantation (a Single Center Study Using Surveillance Renal Biopsies)
-
De Novo Glomerulonephritis after Non Renal Abdominal Organ Transplantation
-
De Novo Hepatitis B Virus Infection after Pediatric Living Donor Liver Transplantation: Risk Factors, Recognition and Prevention Strategies
-
De-Novo Letermovir Resistant Mutations in Cytomegalovirus-Infected Tissues of Solid Organs Transplant Recipients
-
Decay Accelerating Factor (DAF) Regulates Germinal Center B-cell and Alloantibody Formation
-
Deceased Donor Predictors for Pediatric Liver Allograft Utilization and Outcome of the Use of Paediatric Donor Livers in Adult Recipients
-
Deceased Donor Vascularized Abdominal Wall Allograft Procurement – Lessons Learned from Early Experiences
-
Deceased-Donor Acute Kidney Injury Associates with Less BK Viremia in Kidney Transplant Recipients
-
Decline in Club Cell Secretory Protein Results in Immune Responses to Lung Self-Antigens (Kα1 Tubulin and Collagen V) and Development of Chronic Rejection Following Human Lung Transplantation
-
Decreased Cancer Susceptibility in Tolerant Liver Transplant Recipients: Another Benefit of Tolerance?
-
Decreased Rejection and Higher Graft Survival in Pediatric Deceased Donors
-
Defatting Steatotic Rat Livers during Ex Situ Normothermic Perfusion Improves Lactate Clearance and Bile Quality
-
Deficiency of IRE1a Ameliorates Renal Allograft Injury via Remodeling of Graft-Infiltrating Macrophages
-
Deficiency of the Transcription Factor Satb1 in T Cells Promotes Solid Organ Allograft Survival
-
Delayed Achievement of Therapeutic Tacrolimus Levels with De Novo Extended-Release Tacrolimus Tablets and the Incidence of Rejection in Kidney Transplant Patients
-
Delayed Graft Function as a Survival Prognostic Factor in Elderly Recipients of Kidney Transplantation
-
Delayed Kidney Transplantation in Combined Liver Kidney Transplantation: A Validation Analysis by the UNOS Registry
-
Dendritic Cells Transduced with Autoimmune Regulator Exhibit Immature Properties and Prolong Heart Allograft Survival
-
Depleting Laminin α5 in Lymph Node Stromal Cells Promotes Transplant Tolerance
-
Depletional Induction Therapy in Non-Human Primates – Preclinical Modeling of Polyclonal Depletion with Rhesus-Specific ATG
-
Desensitization Protocols vs Kidney Paired Donation to Overcome AB0 Incompatibility and/or Donor Specific Antibodies in Living Donor Kidney Transplantation
-
Desensitization Using Costimulatory Blockade and Bortezomib Does Not Prevent DSA Formation and Rejection in Reconstructive Transplantation
-
Desensitization Using Only IVIG: Is That an Option for Highly-Sensitized Patients Waiting for Kidneys from Cadaveric Donors?
-
Desensitization Using Only Polyvalent Immunoglobulins (IVIG) for Kidney Transplantation with Living Donors (LD)
-
Detection and Desensitization of Donor-Specific Antibody Reduces Risk of Early but Not Late Renal Transplant Failure in a Cohort of 1000 Cases
-
Determinants of Allograft Injury during Procurement in Deceased Donors
-
Determining the Molecular Nature and Role of Cytoglobin in Chronic Allograft Nephropathy
-
Determining the Role of Insurance Coverage at the Time of Renal Transplantation as a Predictor of Medication Misadventure
-
Developing a Patient Reported Outcome Measure for Assessment of Calcineurin Inhibitor-Related Symptoms
-
Developing a Patient Specific Search: Feedback from Kidney Transplant Candidates and Recipients
-
Development and Characterization of Human-Derived Xenograft Model for Hepatocellular Carcinoma
-
Development and Implementation of a Pediatric Transplant Consortium
-
Development and Validation of a Capillary Blood Mitra-Based Assay for the Quantitative Determination of Advagraf® Concentrations in Transplant Patients
-
Development of a Novel Linear Model for Predicting Recipient’s Post-Transplant Serum Creatinine Level after Living Donor Kidney Transplantation: A Multicenter Cross-Validation Study
-
Development of a Pharmacy Collaborative Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic
-
Development of a Recurrence Risk Score in IgA Nephropathy after Kidney Transplantation: Role of Recipient Age and HLA-B Mismatch
-
Development of an Aggressiveness Report Card
-
Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
-
Development of De Novo DSA after Kidney Transplant Correlates with Low Quantity of Peripheral Blood “Antibody-Suppressor” CD8+ T Cells
-
Development of Non-Human Leukocyte Antigen Antibodies in Cardiac Antibody-Mediated Rejection
-
Diagnostic Efficacy of Color Doppler Ultrasound on Recipients with Transplanted Renal Artery Stenosis: A Single Center Experience
-
Dialysis Facility Profit Status and Referral for Kidney Transplantation
-
Dialysis Facility Provider Transplant Knowledge after a Randomized Multilevel Intervention to Increase Kidney Transplant Referral and Evaluation in the Southeast
-
Dialysis Lowers Pulmonary Embolism Mortality Risk in Kidney Transplantation
-
Diastolic Blood Pressure Derived from Twenty Four Hour Ambulatory Blood Pressure Monitoring Predicts Survival after Kidney Transplantation
-
Dichotomous Role Of Donor T Cells In The Efficacy Of Tolerogenic Therapies For Transplant Rejection
-
Did COIIN Cohort A Maintain Graft Survival Performance While Increasing Moderate to High KDPI Transplants?
-
Difference in DSA Formation between Tacrolimus-XR and Tacrolimus-IR
-
Differences in CMV-Specific CD4 T Cell Population in De Novo Kidney Transplant Recipients Treated with Everolimus-Based Regimen Compared to a Standard Tacrolimus-MPA Regimen: Results from ATHENA
-
Differences in Graft Survival for Pediatric and Adult Kidney Recipients Followed and Lost to Follow-Up
-
Differences in the Cost of Kidney Organ Recovery by Organ Procurement Organization Size
-
Differences in the Cost of Recovering Organs over Time
-
Differences in Wait Time, Graft Quality and Outcome for Pediatric Kidney Recipients in the Post-Kidney Allocation System Era
-
Differences of Gut Microbiota Composition between Donor and Recipient May Predict 1-Year Graft Function
-
Different Options Available For Patients Registered In A Kidney Paired Donation (KPD) Program
-
Differential Diagnosis of Membranous Nephropathy Occurs after Bone Marrow Transplantation and Renal Transplantation
-
Differential Effects Of Prolonged Cold Ischemia On Outcomes In Donation After Cardio Circulatory Death Versus Acute Kidney Injury Donor Kidney Transplants
-
Differential Expression of B Cell Activating Factor in Experimental Models of Acute and Chronic Active Antibody-Mediated Rejection
-
Differential Impact of Donor and Recipient Age on Post-Lung Transplantation Outcomes
-
Differential Regulation of Phosphokinases by Anti-HLA Class I and 11 Antibodies
-
Differentiation and Characterization of Human Endodermal Precursors for Liver Cell Therapies
-
Difficult Outflow Reconstruction Using Eptfe Vascular Grafts In Ldlt: Technical Innovations And Outcomes.
-
Digital Imaging Software vs. the “Eyeball” Method in Quantifying Steatosis in a Liver Biopsy
-
Diminishing Scientific Registry of Transplant Recipients Risk-Adjusted Mortality: Reaction to Flagging, Artifact of Modeling, or Both?
-
Direct Oral Anticoagulants: An Evaluation of the Safety and Efficacy in Solid Organ Transplant Recipients
-
Discard Patterns in Donors with Non Alcoholic Fatty Liver Disease
-
Discovery and Validation of an Early Post-Transplant Biomarker Model Predictive of Chronic Kidney Disease in Liver Transplant Recipients
-
Discovery and Validation of Blood Genomic Signatures of Acute Rejection in Liver Transplant Recipients
-
Disparities in Pediatric Liver Transplant Waitlist Access
-
Dissecting The Role Of Donor Acute Kidney Injury On Molecular Responses Post-transplantation
-
Distinct Delayed Classical Complement Pathway Activation Highlights Transition of Ischemic Acute Kidney Injury to Chronic Kidney Disease with Interstitial Fibrosis/Tubular Atrophy
-
Distribution And Outcomes Of Donor Right Kidneys In A National Paired Kidney Exchange Program
-
Do Heart Transplant Patients Have Support Personnel Ready to Help Them If Necessary?
-
Do Outcomes Differ in Glomerulitis Predominant Antibody Mediated Rejection and Peritubular capillaritis Predominant Antibody Mediated Rejection?
-
Do Reimbursement Programs Increase The Number Of Living Organ Donations?
-
Dobutamine Stress Echocardiography is a Poor Predictor of Clinically Significant Coronary Artery Disease in Patients Undergoing Liver Transplant Evaluation
-
Does Ethnicity Impact Elderly Kidney Transplant Recipient Outcomes?
-
Does Proton Pump Inhibitor Use Affect Renal Function in Kidney Transplant Recipients?
-
Does Secondary Simultaneous Liver Kidney versus Liver Alone Make a Difference in Terms of Patient and Graft Survival
-
Does the Type of Pre-Heart Transplant Desensitization Therapy Affect 5-Year Post-Transplant Outcomes?
-
DOME: A New Strategy for Prioritizing Hepatocellular Carcinoma Patients on the Liver Transplant Waitlist
-
Don’t Believe the Hype: Machine Learning-Based Prediction of Kidney Transplant Outcomes
-
Donate HCV Trial: Transplanting Thoracic Organs from Hepatitis C Donors to Uninfected Patients
-
Donation after Cardiac Simultaneous Liver-Kidney: An Updated Perspective
-
Donation After Circulatory Death Kidneys With Prolonged Delayed Graft Function Present Widespread Metabolic And Translational Deficiencies At Time Of Retrieval
-
Donor – Recipient Size Mismatch Has No Impact on Outcomes after Deceased Donor Whole Liver Transplantation: A Single Center Analysis
-
Donor And Recipient Age Matching Versus Mismatching In Expanded Criteria Donor Kidney Transplants: Does It Make A Difference?
-
Donor Brain Death Affects Tolerance Induction in Non-Human Primates
-
Donor Derived Cell Free DNA (dd-cfDNA) May Aid in the Diagnosis of BK Virus Nephropathy
-
Donor Derived Cell Free DNA Initiates De-Novo Donor Specific Antibody (DSA) Responses
-
Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?
-
Donor Derived Strongyloidiasis, a Preventable Event
-
Donor Derived Tuberculosis in Solid Organ Transplantation in the United States: 10 Years of UNOS Ad Hoc Disease Transmission Advisory Committee Experience
-
Donor Exclusions and Shifting Trends in Living Liver Donor Evaluations: A Single Center Experience
-
Donor Graft CMV Serostatus Influences the Development of Arterial and Venous Vascular Events in Seronegative Recipients after Organ Transplantation
-
Donor Hepatitis C Seropositivity Confers Poorer Post-transplant Outcomes In Recipients Of Marginal Livers In The Post-hepatitis C Treatment Era
-
Donor Insulin Therapy Predicts Better Graft Survival in Pancreas Transplantation
-
Donor Lymphocyte Chimerism and Homozygosity Are Critical Indicators for Timely and Accurate Diagnosis of Acute Graft vs. Host Disease after Liver Transplantation
-
Donor Management in Donation after Brain Death: A Window of Opportunity – Are Pro-Inflammatory Mediators the Target and What is the Effect of Duration of Brain Death?
-
Donor Renal Macrophages in Post-Transplant Ischemia/Reperfusion Injury (IRI): Role of IL-1R8 in Modulating Fate, Phenotype and Function
-
Donor Safety for Minimal Invasive Hepatectoy in Liver Transplantation: The Korean Organ Transplantation Registry
-
Donor Source of Kidney Transplantation in New Zealand by Ethnicity: A Longitudinal Cohort Study
-
Donor-Derived Carbapenem-Resistant Klebsiella Pneumoniae Infection after Renal Transplantation
-
Donor-Derived Cell-Free DNA (dd-cfDNA) Course after Rejection in Pediatric Kidney Transplant Recipients
-
Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients, Can We Extrapolate from Kidney Transplant Alone?
-
Donor-derived Cell-free Dna In Donor Specific Antibody Positive Kidney Transplant Recipients
-
Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients
-
Donor-Derived Cell-Free DNA is Associated Specifically with Antibody Mediated Injury in Patients with Renal Allograft Dysfunction
-
Donor-Recipient HLA Mismatched Peptides Calculated by PIRCHE Algorithm Associate with De Novo Donor-Specific Cellular and Humoral Alloreactivity and Predicts Inferior Graft Outcome
-
Donor-Recipient Matching in Kidney Transplant: The Whole is Greater Than the Sum of the Parts
-
Donor-Specific Tregs Prolong Peripheral Chimerism in Baboons Receiving GalTKO hCD47-tg Porcine Peripheral Blood Stem Cells
-
Donor, Recipient Indices and Frailty Predict Outcomes after Heart-Kidney Transplantation
-
Donors and Drugs: How Often Do They Mix? Utilization of Donors Based on Toxicology Findings
-
Dosing and Exposure over 2 Years with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac) in De Novo Kidney Transplantation
-
Dosing Requirements Of Astagraf Xl In African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus (aaaktrs)
-
DR53, You Can’t See Me: A Deceased Donor Tale of Ambiguous Typing
-
Drug Metabolizing Capacity Of The Liver In Liver Donors Recovers Fully By One Month Post Donation
-
Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates
-
Dual Treatment of CD40 Silencing or Mesenchymal Stem Cells Infusion with Sub-Therapeutic Doses of Cyclosporine Effectively Prevents Acute Rejection in an Allogenic Model of Renal Transplantation
-
Dynamic Characterization of Cells in the Perfusate from Cold Ischemic Liver Grafts
2019 American Transplant Congress
June 1-5, 2019 in Boston, MA